Clinical Trials on Prolapse in Singapore

Total 3 results

National University Hospital, Singapore
Celgene

Unknown

Efficacy and Toxicity Study of Pomalidomide and Dexamethasone in Patients Who Have Relapsed After Exposure to Lenalidomide and Bortezomib

Multiple Myeloma | Relapse After Use of Lenalidomide and Bortezomib

Singapore
National University Hospital, Singapore
Janssen, LP; International Myeloma Foundation

Unknown

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

Relapse and / or Refractory Myeloma

Singapore, Hong Kong, Taiwan, Korea, Republic of
National University Hospital, Singapore
Celgene; International Myeloma Foundation

Unknown

Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma

Relapse Multiple Myeloma

Singapore, Hong Kong, Japan, Korea, Republic of, Taiwan

3

Subscribe